跳至主要内容
临床试验/CTRI/2018/08/015198
CTRI/2018/08/015198已完成未知

An open â??label, parallel group, randomized clinical trial to compare the efficacy and safety of 10% KOH and 0.5% Podophyllotoxin for the treatment of Molluscum Contagiosum - KOHPDX

Dr Niharika Ranjan Lal0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • patients of all ages and both sexes who are diagnosed with a MC infection (clinical diagnosis).
  • who have provided written informed consent for participation.

排除标准

  • Immunocompromised patient (congenital or acquired).
  • Patient has received other topical treatment within the last month.
  • Pregnant and lactating women.
  • Patient who, in the view of the attending physician, will not comply with treatment and/or scheduled visits.

研究者

发起方
Dr Niharika Ranjan Lal

相似试验